Unknown

Dataset Information

0

Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016: A Systematic Analysis for the Global Burden of Disease Study.


ABSTRACT: Importance:The increasing burden due to cancer and other noncommunicable diseases poses a threat to human development, which has resulted in global political commitments reflected in the Sustainable Development Goals as well as the World Health Organization (WHO) Global Action Plan on Non-Communicable Diseases. To determine if these commitments have resulted in improved cancer control, quantitative assessments of the cancer burden are required. Objective:To assess the burden for 29 cancer groups over time to provide a framework for policy discussion, resource allocation, and research focus. Evidence Review:Cancer incidence, mortality, years lived with disability, years of life lost, and disability-adjusted life-years (DALYs) were evaluated for 195 countries and territories by age and sex using the Global Burden of Disease study estimation methods. Levels and trends were analyzed over time, as well as by the Sociodemographic Index (SDI). Changes in incident cases were categorized by changes due to epidemiological vs demographic transition. Findings:In 2016, there were 17.2 million cancer cases worldwide and 8.9 million deaths. Cancer cases increased by 28% between 2006 and 2016. The smallest increase was seen in high SDI countries. Globally, population aging contributed 17%; population growth, 12%; and changes in age-specific rates, -1% to this change. The most common incident cancer globally for men was prostate cancer (1.4 million cases). The leading cause of cancer deaths and DALYs was tracheal, bronchus, and lung cancer (1.2 million deaths and 25.4 million DALYs). For women, the most common incident cancer and the leading cause of cancer deaths and DALYs was breast cancer (1.7 million incident cases, 535?000 deaths, and 14.9 million DALYs). In 2016, cancer caused 213.2 million DALYs globally for both sexes combined. Between 2006 and 2016, the average annual age-standardized incidence rates for all cancers combined increased in 130 of 195 countries or territories, and the average annual age-standardized death rates decreased within that timeframe in 143 of 195 countries or territories. Conclusions and Relevance:Large disparities exist between countries in cancer incidence, deaths, and associated disability. Scaling up cancer prevention and ensuring universal access to cancer care are required for health equity and to fulfill the global commitments for noncommunicable disease and cancer control.

SUBMITTER: Global Burden of Disease Cancer Collaboration 

PROVIDER: S-EPMC6248091 | biostudies-literature | 2018 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016: A Systematic Analysis for the Global Burden of Disease Study.

Fitzmaurice Christina C   Akinyemiju Tomi F TF   Al Lami Faris Hasan FH   Alam Tahiya T   Alizadeh-Navaei Reza R   Allen Christine C   Alsharif Ubai U   Alvis-Guzman Nelson N   Amini Erfan E   Anderson Benjamin O BO   Aremu Olatunde O   Artaman Al A   Asgedom Solomon Weldegebreal SW   Assadi Reza R   Atey Tesfay Mehari TM   Avila-Burgos Leticia L   Awasthi Ashish A   Ba Saleem Huda Omer HO   Barac Aleksandra A   Bennett James R JR   Bensenor Isabela M IM   Bhakta Nickhill N   Brenner Hermann H   Cahuana-Hurtado Lucero L   Castañeda-Orjuela Carlos A CA   Catalá-López Ferrán F   Choi Jee-Young Jasmine JJ   Christopher Devasahayam Jesudas DJ   Chung Sheng-Chia SC   Curado Maria Paula MP   Dandona Lalit L   Dandona Rakhi R   das Neves José J   Dey Subhojit S   Dharmaratne Samath D SD   Doku David Teye DT   Driscoll Tim R TR   Dubey Manisha M   Ebrahimi Hedyeh H   Edessa Dumessa D   El-Khatib Ziad Z   Endries Aman Yesuf AY   Fischer Florian F   Force Lisa M LM   Foreman Kyle J KJ   Gebrehiwot Solomon Weldemariam SW   Gopalani Sameer Vali SV   Grosso Giuseppe G   Gupta Rahul R   Gyawali Bishal B   Hamadeh Randah Ribhi RR   Hamidi Samer S   Harvey James J   Hassen Hamid Yimam HY   Hay Roderick J RJ   Hay Simon I SI   Heibati Behzad B   Hiluf Molla Kahssay MK   Horita Nobuyuki N   Hosgood H Dean HD   Ilesanmi Olayinka S OS   Innos Kaire K   Islami Farhad F   Jakovljevic Mihajlo B MB   Johnson Sarah Charlotte SC   Jonas Jost B JB   Kasaeian Amir A   Kassa Tesfaye Dessale TD   Khader Yousef Saleh YS   Khan Ejaz Ahmad EA   Khan Gulfaraz G   Khang Young-Ho YH   Khosravi Mohammad Hossein MH   Khubchandani Jagdish J   Kopec Jacek A JA   Kumar G Anil GA   Kutz Michael M   Lad Deepesh Pravinkumar DP   Lafranconi Alessandra A   Lan Qing Q   Legesse Yirga Y   Leigh James J   Linn Shai S   Lunevicius Raimundas R   Majeed Azeem A   Malekzadeh Reza R   Malta Deborah Carvalho DC   Mantovani Lorenzo G LG   McMahon Brian J BJ   Meier Toni T   Melaku Yohannes Adama YA   Melku Mulugeta M   Memiah Peter P   Mendoza Walter W   Meretoja Tuomo J TJ   Mezgebe Haftay Berhane HB   Miller Ted R TR   Mohammed Shafiu S   Mokdad Ali H AH   Moosazadeh Mahmood M   Moraga Paula P   Mousavi Seyyed Meysam SM   Nangia Vinay V   Nguyen Cuong Tat CT   Nong Vuong Minh VM   Ogbo Felix Akpojene FA   Olagunju Andrew Toyin AT   Pa Mahesh M   Park Eun-Kee EK   Patel Tejas T   Pereira David M DM   Pishgar Farhad F   Postma Maarten J MJ   Pourmalek Farshad F   Qorbani Mostafa M   Rafay Anwar A   Rawaf Salman S   Rawaf David Laith DL   Roshandel Gholamreza G   Safiri Saeid S   Salimzadeh Hamideh H   Sanabria Juan Ramon JR   Santric Milicevic Milena M MM   Sartorius Benn B   Satpathy Maheswar M   Sepanlou Sadaf G SG   Shackelford Katya Anne KA   Shaikh Masood Ali MA   Sharif-Alhoseini Mahdi M   She Jun J   Shin Min-Jeong MJ   Shiue Ivy I   Shrime Mark G MG   Sinke Abiy Hiruye AH   Sisay Mekonnen M   Sligar Amber A   Sufiyan Muawiyyah Babale MB   Sykes Bryan L BL   Tabarés-Seisdedos Rafael R   Tessema Gizachew Assefa GA   Topor-Madry Roman R   Tran Tung Thanh TT   Tran Bach Xuan BX   Ukwaja Kingsley Nnanna KN   Vlassov Vasiliy Victorovich VV   Vollset Stein Emil SE   Weiderpass Elisabete E   Williams Hywel C HC   Yimer Nigus Bililign NB   Yonemoto Naohiro N   Younis Mustafa Z MZ   Murray Christopher J L CJL   Naghavi Mohsen M  

JAMA oncology 20181101 11


<h4>Importance</h4>The increasing burden due to cancer and other noncommunicable diseases poses a threat to human development, which has resulted in global political commitments reflected in the Sustainable Development Goals as well as the World Health Organization (WHO) Global Action Plan on Non-Communicable Diseases. To determine if these commitments have resulted in improved cancer control, quantitative assessments of the cancer burden are required.<h4>Objective</h4>To assess the burden for 2  ...[more]

Similar Datasets

| S-EPMC6777271 | biostudies-literature
| S-EPMC6103527 | biostudies-literature
| S-EPMC8719276 | biostudies-literature
| S-EPMC9208127 | biostudies-literature
| S-EPMC8207592 | biostudies-literature
| S-EPMC7462312 | biostudies-literature
| S-EPMC10240458 | biostudies-literature